Receives 4 observations under Form 483
Marksans Pharma announced that the United States Food & Drug Administration inspected its manufacturing facility located at Goa from 03 April to 07 April 2017. At the end of the inspections, there were 4 (four) observations given under Form 483. The company is already addressing the same and is confident of satisfying the FDA within stipulated time.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
